Lagita Advance Tablet contains Sodium Alginate as its active ingredient. Sodium Alginate is a natural polysaccharide derived from seaweed, belonging to a class of medications known as alginate-based reflux suppressants. It is commonly used to relieve symptoms of gastroesophageal reflux disease (GERD) and related conditions by forming a protective barrier in the stomach to prevent acid reflux into the esophagus.
Ingredients:
- Sodium Alginate: Sodium Alginate forms a gel-like layer on the surface of gastric contents when it comes into contact with stomach acid. This gel barrier floats on the stomach contents, acting as a physical barrier to prevent acid reflux and relieve symptoms such as heartburn and regurgitation.
Uses:
- Gastroesophageal Reflux Disease (GERD): Lagita Advance Tablet is indicated for the symptomatic treatment of GERD, a condition characterized by the reflux of stomach acid into the esophagus, leading to symptoms such as heartburn, acid regurgitation, and chest pain.
- Acid Indigestion: It may also be used to relieve symptoms of acid indigestion, including sour stomach, bloating, and discomfort caused by excessive stomach acid.
- Hiatal Hernia: Lagita Advance Tablet can help alleviate symptoms associated with hiatal hernia, a condition where part of the stomach protrudes into the chest cavity, leading to increased risk of acid reflux and heartburn.
Side Effects:
Lagita Advance Tablet is generally well-tolerated when used as directed. However, some individuals may experience mild gastrointestinal side effects, such as bloating, flatulence, or diarrhea. These symptoms are usually transient and resolve with continued use or dosage adjustment.
Precautions:
- Drug Interactions: Lagita Advance Tablet may interfere with the absorption of other medications if taken concurrently. It is advisable to take Lagita Advance Tablet at least 2 hours apart from other medications to minimize potential interactions.
- Pregnancy and Breastfeeding: There are limited data on the safety of Sodium Alginate use during pregnancy or breastfeeding. Consultation with a healthcare professional is recommended before initiating treatment in pregnant or lactating women.
When Not to Use:
Lagita Advance Tablet is contraindicated in individuals with known hypersensitivity to Sodium Alginate or any component of the tablet. It should not be used as the sole treatment for severe or complicated GERD, such as erosive esophagitis or Barrett’s esophagus, without medical supervision.
FAQ:
- How should Lagita Advance Tablet be taken?
- Lagita Advance Tablet is typically taken orally, usually after meals or at bedtime, as directed by a healthcare professional. The tablet should be chewed thoroughly and followed by a glass of water to ensure proper formation of the protective gel barrier.
- How long does it take for Lagita Advance Tablet to work?
- The onset of action of Lagita Advance Tablet may vary but is generally rapid, with relief of symptoms occurring within minutes of administration. However, the duration of symptom relief may vary among individuals.
- Can Lagita Advance Tablet be used long-term?
- Lagita Advance Tablet may be used for long-term symptomatic relief of GERD and related conditions, especially in individuals with recurrent or persistent symptoms. However, regular follow-up with a healthcare professional is advisable to monitor treatment efficacy and adjust therapy as needed.
- Are there any dietary restrictions while taking Lagita Advance Tablet?
- While there are no specific dietary restrictions associated with Lagita Advance Tablet, individuals with GERD may benefit from dietary modifications such as avoiding spicy or acidic foods, caffeine, alcohol, and large meals, which can exacerbate symptoms of acid reflux.
- Can Lagita Advance Tablet be used in children?
- Lagita Advance Tablet may be used in children under medical supervision and according to dosage recommendations based on age and weight. It is important to consult a healthcare professional before administering Lagita Advance Tablet to children.
Reviews
There are no reviews yet.